Skip to main content

Botswana

Tariffs

Download data

3002.41 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products, vaccines for human medicine

3 tariff lines

3002.41 Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products, vaccines for human medicine
HS code Product MFN AfCFTA EFTA EU-SADC EPA SADC MERCOSUR
3002.41.11 Vaccines for human medicine 0% – – – 0% –
3002.41.19 Vaccines for human medicine 0% – – – 0% –
3002.41.90 Vaccines for human medicine 0% – – – 0% –

Showing 1–3 of 3

HS 3002.41.90

Vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products, vaccines for human medicine

Section VI · Products of the chemical & allied industries › Ch 30 Pharmaceutical products › 30.02 Human blood; animal blood prepared for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions and immunological products, whether or not modified or obtained by means of biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) and similar products; cell cultures, whether or not modified

Close

Applied duty rates

  • 0% MFN applied rate
  • 0% SADC preferential rate
Exports | US$ thousand
  • To the world
  • Within the Commonwealth
Show data
YearTo the worldWithin the Commonwealth
2020$0$0
2021$0$0
2022$0$0
2023$1$1
2024$0$0
Imports | US$ thousand
  • From the world
  • Within the Commonwealth
Show data
YearFrom the worldWithin the Commonwealth
2020$0$0
2021$0$0
2022$3,295$520
2023$5,921$1,442
2024$4,993$780

Pilot countries

Each country has its own profile: tariff regime, export requirements, a market snapshot and links to official national portals. 

See all countries

Share this page with